Live Breaking News & Updates on Cyclo Therapeutics
Stay updated with breaking news from Cyclo therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright assumed coverage on shares of Cyclo Therapeutics (NASDAQ:CYTH – Free Report) in a research report sent to investors on Wednesday morning, Marketbeat reports. The firm issued a buy rating and a $3.00 target price on the stock. HC Wainwright also issued estimates for Cyclo Therapeutics’ Q1 2024 earnings at ($0.20) EPS, Q2 2024 […] ....
HC Wainwright began coverage on shares of Cyclo Therapeutics (NASDAQ:CYTH – Free Report) in a research note published on Wednesday, Marketbeat Ratings reports. The firm issued a buy rating and a $3.00 price target on the stock. HC Wainwright also issued estimates for Cyclo Therapeutics’ Q1 2024 earnings at ($0.20) EPS, Q2 2024 earnings at […] ....
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Free Report) – Analysts at HC Wainwright issued their Q1 2024 EPS estimates for Cyclo Therapeutics in a research note issued to investors on Wednesday, May 1st. HC Wainwright analyst S. Ramakanth expects that the company will post earnings of ($0.20) per share for the quarter. HC Wainwright has a […] ....
Cyclo Therapeutics (NASDAQ:CYTH) Earns Buy Rating from Analysts at Ascendiant Capital Markets themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.